Stifel Nicolaus analyst Daniel Arias has maintained their neutral stance on WAT stock, giving a Hold rating today.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Daniel Arias has given his Hold rating due to a combination of factors surrounding Waters’ recent strategic move. The company announced a significant merger with Becton, Dickinson and Company’s Bioscience/Dx business, valued at approximately $17.5 billion. This transaction is expected to transform Waters by expanding its product portfolio and organizational scale, which could potentially lead to increased revenue and earnings per share growth.
However, the complexity and size of the deal introduce uncertainties, particularly regarding the integration of the new business and the realization of projected synergies. While the acquisition is strategically sound, the challenges associated with such a large-scale transaction warrant a cautious approach. Therefore, the Hold rating reflects both the potential benefits and the risks involved in this transformative deal.
In another report released today, Bank of America Securities also maintained a Hold rating on the stock with a $375.00 price target.